DO-10

Indicaton

GM1-gangliosidosis and mucopolysaccharidosis IVB, 2 rare diseases caused by beta-galactosidase deficiency.

Therapeutic indications

Metabolic disorder

Type of product

Small molecule

Table

Phase

Discovery
Available in

EU, US, Japan

You may also be interested in

OligoPhore / SemaPhore Peptide-Based RNA Delivery Platforms

Delivers siRNA, antisense oligonucleotides, mRNA and other mRNA modalities to extrahepatic tissues - demonstrated across various indications in oncology (e.g. PDAC, breast cancer, ovarian cancer, lung cancer, melanoma, ATLL, TME), and inflammatory / autoimmune diseases (e.g. OA, RA, enterocolitis), CV (e.g. atherosclerosis, aortic aneurysm)

Discovery

Sublingual semaglutide

obesity and diabetes

Discovery

A2AR positive allosteric modulator

Multiple, see therapeutic areas. GI indications also relevant.

Discovery